Our unique in vivo mass screening platform

Simultaneous screening of hundreds of different nanoparticle formulations through the use of an innovative molecular barcoding technology with a rapid in vivo feedback loop for improving selective delivery. We can simultaneously identify and quantify the biodistribution of nanoparticles at a single-cell resolution.

Coupled with AI analysis, this technology enables in vivo screening of hundreds of different LNP formulations in a single experiment to develop the optimal nanoparticle for each target.